Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: May 18, 2022
Date Accepted: Oct 25, 2022

The final, peer-reviewed published version of this preprint can be found here:

Using Intervention Mapping to Develop an mHealth Intervention to Support Men Who Have Sex With Men Engaging in Chemsex (Budd): Development and Usability Study

Herrijgers C, Platteau T, Vandebosch H, Poels K, Florence E

Using Intervention Mapping to Develop an mHealth Intervention to Support Men Who Have Sex With Men Engaging in Chemsex (Budd): Development and Usability Study

JMIR Res Protoc 2022;11(12):e39678

DOI: 10.2196/39678

PMID: 36542451

PMCID: 9813820

A mobile health intervention (BUDD) to support men who have sex with men engaging in chemsex: Intervention Mapping Approach

  • Corinne Herrijgers; 
  • Tom Platteau; 
  • Heidi Vandebosch; 
  • Karolien Poels; 
  • Eric Florence

ABSTRACT

Background:

Chemsex refers to the use of drugs for or during sex among men who have sex with men (MSM). Engaging in chemsex has been linked to significant negative impacts on physical, psychological, and social wellbeing. However, there have been no evidence-based support tools that address these harms and the care needs of MSM who engage in chemsex (MWEC).

Objective:

The purpose of this paper is to describe how we developed a mobile health intervention (named ‘Budd’) using the Intervention Mapping Protocol (IMP). Budd aims to support and inform MWEC, and reduce the negative impacts associated with chemsex and encourage more reasoned participation.

Methods:

The IMP consists of six steps to develop, implement, and evaluate evidence-based health interventions. A literature study and in-depth interviews assessed the chemsex health problem, associated health risks and its determinants. Change objectives were selected based on these findings, after which theory-based intervention methods were selected. A first version of the intervention was developed and pilot tested. Adjustments were made based on findings from this study. A separate article will be dedicated to the effectiveness study and implementation of the intervention.

Results:

The Budd app consists of harm reduction information and individual support tools. The information module contains articles on chemsex topics, user testimonials, drug information, a drug combination tool, emergency information, and an overview of existing local healthcare and peer support services. The app can also be used to better understand one's chemsex participation and participate more consciously by using a preparation tool and event-specific checklist, fill in a mood survey, reflect, check personal statistics, and write in a notebook during the event.

Conclusions:

The application of IMP is a time-intensive but thorough way to ensure that each step of developing an intervention is taken. It proved to be a valuable tool in the planning and development of the Budd app. This study provides researchers and practitioners with valuable information that may help them in setting up their own health interventions. Further research should test the effectiveness of the Budd app.


 Citation

Please cite as:

Herrijgers C, Platteau T, Vandebosch H, Poels K, Florence E

Using Intervention Mapping to Develop an mHealth Intervention to Support Men Who Have Sex With Men Engaging in Chemsex (Budd): Development and Usability Study

JMIR Res Protoc 2022;11(12):e39678

DOI: 10.2196/39678

PMID: 36542451

PMCID: 9813820

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.